+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Incidence and risk factors for neovascular age-related macular degeneration in the fellow eye



Incidence and risk factors for neovascular age-related macular degeneration in the fellow eye



Graefe's Archive for Clinical and Experimental Ophthalmology 256(11): 2061-2068



The epidemiology, risk factors, and the effect of anti-VEGF treatment on neovascular age-related macular degeneration (nAMD) have primarily been studied in the first eye developing the disease. The understanding of pathophysiology and planning of follow-up examinations can be improved by knowledge of incidence and risk factors for development of the disease in the fellow eye. In a prospective observational cohort study, epidemiological and clinical risk factors for the development of nAMD in the fellow eye among 2516 patients consecutively diagnosed with the disease from a population of 0.9 million citizens during a period of more than 10 years were studied. nAMD had been diagnosed in the fellow eye of 541 (21.5%) of the patients. The incidence of fellow-eye involvement increased from approximately 5% in patients initially presenting with bilateral disease to approximately 28% more than 6 years after the diagnosis in the first eye. Visual acuity (VA) was higher and central retinal thickness (CRT) was lower in fellow eyes with nAMD diagnosed later than the first eye. Male gender, increasing leakage area, and peripapillary location of the subretinal neovascular membrane in the first eye reduced the risk of developing disease in the fellow eye. The planning of follow-up examinations of patients diagnosed with nAMD in one eye should consider that the risk of fellow-eye involvement is higher within the first 6 years, in women, and when the leakage area in the first eye is small and not located peripapillary.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065230610

Download citation: RISBibTeXText

PMID: 30097785

DOI: 10.1007/s00417-018-4100-z


Related references

Incidence and risk factors for macular hemorrhage following intravitreal ranibizumab injection for neovascular age-related macular degeneration. Journal of Ocular Pharmacology and Therapeutics 29(6): 556-559, 2014

Risk to fellow eye of patients with occult neovascular maculopathy secondary to age-related macular degeneration. Investigative Ophthalmology & Visual Science 35(4): 1564, 1994

High-risk characteristics of fellow eyes of patients with unilateral neovascular age-related macular degeneration. Ophthalmology 105(3): 441-447, 1998

A Tablet-Based Retinal Function Test in Neovascular Age-Related Macular Degeneration Eyes and At-Risk Fellow Eye. Translational Vision Science and Technology 7(2): 2, 2018

Choroidal thickness in non-neovascular versus neovascular age-related macular degeneration: a fellow eye comparative study. British Journal of Ophthalmology 101(6): 764-769, 2017

Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration. Retina 35(5): 966-974, 2015

Retinal pigment epithelium rips after ranibizumab in neovascular age-related macular degeneration: incidence, risk factors and long-term outcome. Klinische Monatsblatter für Augenheilkunde 231(4): 432-435, 2014

Pseudodrusen and Incidence of Late Age-Related Macular Degeneration in Fellow Eyes in the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology 123(7): 1530-1540, 2016

Severity of age-related macular degeneration in 1 eye and the incidence and progression of age-related macular degeneration in the fellow eye: the Beaver Dam Eye Study. JAMA Ophthalmology 133(2): 125-132, 2015

Risk factors for neovascular age-related macular degeneration. Archives of Ophthalmology 110(12): 1701-1708, 1992

Description of the fellow eye in newly diagnosed unilateral neovascular age-related macular degeneration. Investigative Ophthalmology & Visual Science 37(3): S113, 1996

Nongenetic risk factors for neovascular age-related macular degeneration. Investigative Ophthalmology and Visual Science 55(8): 5228-5232, 2014

Age-related macular degeneration and risk factors for the development of choroidal neovascularization in the fellow eye. Current Opinion in Ophthalmology 9(3): 38-46, 1998

Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcome. Clinical Ophthalmology 11: 63-70, 2017

Pseudodrusen in the Fellow Eye of Patients with Unilateral Neovascular Age-Related Macular Degeneration: A Meta-Analysis. Plos one 11(2): E0149030, 2016